BiVictriX Therapeutics plc

AIM:BVX Stock Report

Market Cap: UK£8.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BiVictriX Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

BiVictriX Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-25.8%

Buyback Yield

Total Shareholder Yield-25.8%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if BVX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BVX's dividend payments have been increasing.


Dividend Yield vs Market

BiVictriX Therapeutics Dividend Yield vs Market
How does BVX dividend yield compare to the market?
SegmentDividend Yield
Company (BVX)n/a
Market Bottom 25% (GB)2.1%
Market Top 25% (GB)5.8%
Industry Average (Biotechs)1.6%
Analyst forecast (BVX) (up to 3 years)0%

Notable Dividend: Unable to evaluate BVX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BVX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate BVX's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as BVX has not reported any payouts.


Discover strong dividend paying companies